These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17332925)

  • 1. Ephrin-A1 is a negative regulator in glioma through down-regulation of EphA2 and FAK.
    Liu DP; Wang Y; Koeffler HP; Xie D
    Int J Oncol; 2007 Apr; 30(4):865-71. PubMed ID: 17332925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation.
    Brantley-Sieders DM; Caughron J; Hicks D; Pozzi A; Ruiz JC; Chen J
    J Cell Sci; 2004 Apr; 117(Pt 10):2037-49. PubMed ID: 15054110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ephrin-B3 ligand promotes glioma invasion through activation of Rac1.
    Nakada M; Drake KL; Nakada S; Niska JA; Berens ME
    Cancer Res; 2006 Sep; 66(17):8492-500. PubMed ID: 16951161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin.
    Guo H; Miao H; Gerber L; Singh J; Denning MF; Gilliam AC; Wang B
    Cancer Res; 2006 Jul; 66(14):7050-8. PubMed ID: 16849550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness.
    Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
    Biochem Biophys Res Commun; 2004 Aug; 320(4):1096-102. PubMed ID: 15249202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.
    Brantley-Sieders DM; Fang WB; Hwang Y; Hicks D; Chen J
    Cancer Res; 2006 Nov; 66(21):10315-24. PubMed ID: 17079451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases.
    Shi Q; Bao S; Song L; Wu Q; Bigner DD; Hjelmeland AB; Rich JN
    Oncogene; 2007 Jun; 26(28):4084-94. PubMed ID: 17213807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder.
    Abraham S; Knapp DW; Cheng L; Snyder PW; Mittal SK; Bangari DS; Kinch M; Wu L; Dhariwal J; Mohammed SI
    Clin Cancer Res; 2006 Jan; 12(2):353-60. PubMed ID: 16428472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiam1 mediates neurite outgrowth induced by ephrin-B1 and EphA2.
    Tanaka M; Ohashi R; Nakamura R; Shinmura K; Kamo T; Sakai R; Sugimura H
    EMBO J; 2004 Mar; 23(5):1075-88. PubMed ID: 14988728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new ephrin-A1 isoform (ephrin-A1b) with altered receptor binding properties abrogates the cleavage of ephrin-A1a.
    Finne EF; Munthe E; Aasheim HC
    Biochem J; 2004 Apr; 379(Pt 1):39-46. PubMed ID: 14692877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A conditional feedback loop regulates Ras activity through EphA2.
    Macrae M; Neve RM; Rodriguez-Viciana P; Haqq C; Yeh J; Chen C; Gray JW; McCormick F
    Cancer Cell; 2005 Aug; 8(2):111-8. PubMed ID: 16098464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.
    Shi Q; Hjelmeland AB; Keir ST; Song L; Wickman S; Jackson D; Ohmori O; Bigner DD; Friedman HS; Rich JN
    Mol Carcinog; 2007 Jun; 46(6):488-96. PubMed ID: 17219439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eph and ephrin expression in normal placental development and preeclampsia.
    Goldman-Wohl D; Greenfield C; Haimov-Kochman R; Ariel I; Anteby EY; Hochner-Celnikier D; Farhat M; Yagel S
    Placenta; 2004 Aug; 25(7):623-30. PubMed ID: 15193868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-cadherin regulates the function of the EphA2 receptor tyrosine kinase.
    Zantek ND; Azimi M; Fedor-Chaiken M; Wang B; Brackenbury R; Kinch MS
    Cell Growth Differ; 1999 Sep; 10(9):629-38. PubMed ID: 10511313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EphA2 as a novel molecular marker and target in glioblastoma multiforme.
    Wykosky J; Gibo DM; Stanton C; Debinski W
    Mol Cancer Res; 2005 Oct; 3(10):541-51. PubMed ID: 16254188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Eph receptors and their ligands, ephrins, during lipopolysaccharide fever in rats.
    Ivanov AI; Steiner AA; Scheck AC; Romanovsky AA
    Physiol Genomics; 2005 Apr; 21(2):152-60. PubMed ID: 15671251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.
    Lee PC; Chen ST; Kuo TC; Lin TC; Lin MC; Huang J; Hung JS; Hsu CL; Juan HF; Lee PH; Huang MC
    Oncogene; 2020 Mar; 39(13):2724-2740. PubMed ID: 32005975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor EphA2 activation with ephrinA1 suppresses growth of malignant mesothelioma (MM).
    Nasreen N; Mohammed KA; Lai Y; Antony VB
    Cancer Lett; 2007 Dec; 258(2):215-22. PubMed ID: 17949899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing the receptor EphA2 suppresses the growth and haptotaxis of malignant mesothelioma cells.
    Nasreen N; Mohammed KA; Antony VB
    Cancer; 2006 Nov; 107(10):2425-35. PubMed ID: 17041885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of EphA2 promotes tight junction formation and impairs angiogenesis in brain endothelial cells.
    Zhou N; Zhao WD; Liu DX; Liang Y; Fang WG; Li B; Chen YH
    Microvasc Res; 2011 Sep; 82(2):113-21. PubMed ID: 21726568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.